Epidemiology Midterm and Final
Exam Questions and Answers
Updated 2027
OddsBRatioB-BBB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
ProportionateBMortalityB-
BBB(Num.BofBdeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBtime)/(T
otalBdeathsBinBtheBpopulationBatBtheBsameBtime)BXB100
AnnualBMortalityBRateB-
BBB(TotalBnumberBofBdeathsBfromBallBcausesBinB1Byear)/(NumberBofBpersonBiBtheBpo
pulaitonBatBmidyear)BXB1,000
RelativeBSurvivalB-
BBB(ObservedBsurvivalBinBpersonsBwithBtheBdisease)/(ExpectedBsurvivalBifBdiseaseBwer
eBabsent)BXB1,000
CrudeBMortalityBRateB-
BBB(TotalBnumberBofBdeathsBfromBallBcausesBforBaBspecifiedBtimeBperiod)/(TotalBpopu
lationBforBtheBsameBgeographicBareaBforBspecifiedBtimeBperiod)BXB100,000
Case-FatalityB-
BBB(Num.ofBpersonsBdyingBduringBaBspecifiedBtimeBperiodBafterBaBspecificBdiseaseBo
nset)/(Num.ofBpersonsBwithBtheBdiseaseB)BXB100
StandardizedBMortalityBRatioB-
BBB(ObservedBnumberBofBDeathsBperByear)/(ExpectedBnumberBofBDeathsBperByear)BX
B100
,IncidenceBRateB-
BBB(Num.BofBnewBcasesBofBaBdiseaseBoccuringBinBaBpopulationBduringBaBspecifiedBti
meBperiod)/(Num.ofBpersonsBatBriskBofBdevelopingBdiseaseBduringBtheBsameBtimeBper
iod)BXB1,000
PrevalenceB-
BBB(NumberBofBcasesBofBaBdiseaseBpresentBinBaBpopulationBatBaBspecifiedBtime)/(Nu
mberBofBpersonsBinBaBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
KAPPABStatisticB-BBB((PercentBagreementBobserved-
PercentBagreementBexpectedBbyBchanceBalone)B)/((100%-
PercentBagreementBexpectedBbyBchance))
RelativeBRiskB(RiskBRatio)B-BBB(IncidenceBinBExposedB)/(IncidenceBinBtheBnon-exposed)
CauseBSpecificBMortalityBRateB-
BBB(NumberBofBDeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBtime)
/(TotalBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
AttackBRateB-
BBB(NumberBofBpeopleBatBriskBwhoBdevelopBanBillnessBorBdiseaseBoverBaBshortBtime
BperiodB)/(TotalBNumberBofBpersonsBatBriskBforBtheBillnessBorBdiseaseBoverBtheBsame
BtimeBperiod)
SecondaryBAttackBRateB-
BBB(NumberBofBcasesBamongBsusceptibleBcontactsBofBtheBprimaryBcasesB)/(TotalBnum
berBofBcontactsBexposed)BXB1,000
SensitivityB-
BBB(NumberBofBpeopleBwhoBtestBpositiveB)/(NumberBofBpeopleBwithBdiseaseB)BXB100
SpecificityB-
BBB(NumberBofBpeopleBwhoBtestBnegativeB)/(NumberBofBpeopleBdiseaseBfree)BXB100
,OddsBratio-matchedB-BBB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
OddsBRatioB-
BBB(OddsBofBexposureBamongBdiseasedB)/(OddsBofBexposureBamongBnon-diseased)
WhichBstatementBconveysBtheBunderlyingBpremiseBinBepidemiology?B-
BBBDiseaseB(illBhealth)BisBnotBrandomlyBdistributedBinBpopulationsBbyBperson,Btime,B
andBplace
TheBSpanishBFluBofB1917BisBanBexampleBofBa(n)B___________,BbecauseBofBitsBworld
wideBoccurrence.B-BBBPandemic
((𝑁𝑢𝑚𝑏𝑒𝑟B𝑜𝑓B𝑁𝐸𝑊B𝑐𝑎𝑠𝑒𝑠B𝑜𝑓B𝑎B𝑑𝑖𝑠𝑒𝑎𝑠𝑒B𝑜𝑣𝑒𝑟B𝑎B𝑡𝑖𝑚𝑒B𝑝𝑒𝑟𝑖𝑜𝑑)/(𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛B𝑎𝑡B𝑟𝑖𝑠
𝑘B))∗1000B-BBBIncidenceBRate
SensitivityBandBSpecificityBareBmeasuresBofB_________,BoftenBassociatedBwithB______
_________:B-BBBValidityB/BScreeningBTests
InBtheBpriorBquestion,BitBwasBnotedBthatBtheBRelativeBRiskBwasB5.0.BHowBwouldByou
BinterpretBthisBstatistic?
a)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcompare
BtoBnon-exposedBpeople
b)BNegativeBAssociation;BexposedBpeopleBhaveBaBnegativeBexperience
c)BPositiveBAssociation;BexposedBpeopleBareBexactlyB5%BmoreBlikelyBtoBexperienceBth
eBoutcomeB
d)BNegativeBAssociation;BexposedBpeopleBareBexactlyB5BtimesBmoreBlikelyBtoBexperien
ceBtheBoutcomeB-
BBBa)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcom
pareBtoBnon-exposedBpeople
, InB2003BanBepidemicBofBSARsBoccurred.BDuringBtheBepidemicB8098BpeopleBwereBdia
gnosedBwithBSARS,BofBwhichB774BdiedBasBaBresult.BBasedBonBthisBinformationBwhich
BstatisticBcanByouBcalculate?B
a)BMortalityBRate
b)BCase-FatalityB
c)BPerson-TimeBIncidenceB
d)BPrevalenceB-BBBb)BCase-Fatality
Case-
FatalityBandBMortalityBRateBshareBtheBsameB_________,BbutBhaveBdifferentB________
______:
a)BNumerator,BDenominatorsB
b)BDenominator,BNumerator
c)BMorbidBCuriosity,BMeanings
d)BProportion,BInterpretationsB-BBBa)BNumerator,BDenominators
ABcohortBstudyBenrollsBitsBparticipantsBbyB_______BandBthenBmeasuresBtheB_______
_.B
a)Boutcome,BhistoryBofBexposure
b)BdemographicBmetrics,BprevalenceBofBexposure
c)BexposureBstatus,BsubsequentBoutcome
d)BsurveyBalone,BoddsBratiosB-BBBc)BexposureBstatus,BsubsequentBoutcome
WhyBisBitBimportantBtoBunderstandBtheBtemporalBrelationshipBbetweenBanBexposure,B
andBanBoutcome?
Exam Questions and Answers
Updated 2027
OddsBRatioB-BBB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
ProportionateBMortalityB-
BBB(Num.BofBdeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBtime)/(T
otalBdeathsBinBtheBpopulationBatBtheBsameBtime)BXB100
AnnualBMortalityBRateB-
BBB(TotalBnumberBofBdeathsBfromBallBcausesBinB1Byear)/(NumberBofBpersonBiBtheBpo
pulaitonBatBmidyear)BXB1,000
RelativeBSurvivalB-
BBB(ObservedBsurvivalBinBpersonsBwithBtheBdisease)/(ExpectedBsurvivalBifBdiseaseBwer
eBabsent)BXB1,000
CrudeBMortalityBRateB-
BBB(TotalBnumberBofBdeathsBfromBallBcausesBforBaBspecifiedBtimeBperiod)/(TotalBpopu
lationBforBtheBsameBgeographicBareaBforBspecifiedBtimeBperiod)BXB100,000
Case-FatalityB-
BBB(Num.ofBpersonsBdyingBduringBaBspecifiedBtimeBperiodBafterBaBspecificBdiseaseBo
nset)/(Num.ofBpersonsBwithBtheBdiseaseB)BXB100
StandardizedBMortalityBRatioB-
BBB(ObservedBnumberBofBDeathsBperByear)/(ExpectedBnumberBofBDeathsBperByear)BX
B100
,IncidenceBRateB-
BBB(Num.BofBnewBcasesBofBaBdiseaseBoccuringBinBaBpopulationBduringBaBspecifiedBti
meBperiod)/(Num.ofBpersonsBatBriskBofBdevelopingBdiseaseBduringBtheBsameBtimeBper
iod)BXB1,000
PrevalenceB-
BBB(NumberBofBcasesBofBaBdiseaseBpresentBinBaBpopulationBatBaBspecifiedBtime)/(Nu
mberBofBpersonsBinBaBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
KAPPABStatisticB-BBB((PercentBagreementBobserved-
PercentBagreementBexpectedBbyBchanceBalone)B)/((100%-
PercentBagreementBexpectedBbyBchance))
RelativeBRiskB(RiskBRatio)B-BBB(IncidenceBinBExposedB)/(IncidenceBinBtheBnon-exposed)
CauseBSpecificBMortalityBRateB-
BBB(NumberBofBDeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBtime)
/(TotalBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
AttackBRateB-
BBB(NumberBofBpeopleBatBriskBwhoBdevelopBanBillnessBorBdiseaseBoverBaBshortBtime
BperiodB)/(TotalBNumberBofBpersonsBatBriskBforBtheBillnessBorBdiseaseBoverBtheBsame
BtimeBperiod)
SecondaryBAttackBRateB-
BBB(NumberBofBcasesBamongBsusceptibleBcontactsBofBtheBprimaryBcasesB)/(TotalBnum
berBofBcontactsBexposed)BXB1,000
SensitivityB-
BBB(NumberBofBpeopleBwhoBtestBpositiveB)/(NumberBofBpeopleBwithBdiseaseB)BXB100
SpecificityB-
BBB(NumberBofBpeopleBwhoBtestBnegativeB)/(NumberBofBpeopleBdiseaseBfree)BXB100
,OddsBratio-matchedB-BBB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
OddsBRatioB-
BBB(OddsBofBexposureBamongBdiseasedB)/(OddsBofBexposureBamongBnon-diseased)
WhichBstatementBconveysBtheBunderlyingBpremiseBinBepidemiology?B-
BBBDiseaseB(illBhealth)BisBnotBrandomlyBdistributedBinBpopulationsBbyBperson,Btime,B
andBplace
TheBSpanishBFluBofB1917BisBanBexampleBofBa(n)B___________,BbecauseBofBitsBworld
wideBoccurrence.B-BBBPandemic
((𝑁𝑢𝑚𝑏𝑒𝑟B𝑜𝑓B𝑁𝐸𝑊B𝑐𝑎𝑠𝑒𝑠B𝑜𝑓B𝑎B𝑑𝑖𝑠𝑒𝑎𝑠𝑒B𝑜𝑣𝑒𝑟B𝑎B𝑡𝑖𝑚𝑒B𝑝𝑒𝑟𝑖𝑜𝑑)/(𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛B𝑎𝑡B𝑟𝑖𝑠
𝑘B))∗1000B-BBBIncidenceBRate
SensitivityBandBSpecificityBareBmeasuresBofB_________,BoftenBassociatedBwithB______
_________:B-BBBValidityB/BScreeningBTests
InBtheBpriorBquestion,BitBwasBnotedBthatBtheBRelativeBRiskBwasB5.0.BHowBwouldByou
BinterpretBthisBstatistic?
a)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcompare
BtoBnon-exposedBpeople
b)BNegativeBAssociation;BexposedBpeopleBhaveBaBnegativeBexperience
c)BPositiveBAssociation;BexposedBpeopleBareBexactlyB5%BmoreBlikelyBtoBexperienceBth
eBoutcomeB
d)BNegativeBAssociation;BexposedBpeopleBareBexactlyB5BtimesBmoreBlikelyBtoBexperien
ceBtheBoutcomeB-
BBBa)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcom
pareBtoBnon-exposedBpeople
, InB2003BanBepidemicBofBSARsBoccurred.BDuringBtheBepidemicB8098BpeopleBwereBdia
gnosedBwithBSARS,BofBwhichB774BdiedBasBaBresult.BBasedBonBthisBinformationBwhich
BstatisticBcanByouBcalculate?B
a)BMortalityBRate
b)BCase-FatalityB
c)BPerson-TimeBIncidenceB
d)BPrevalenceB-BBBb)BCase-Fatality
Case-
FatalityBandBMortalityBRateBshareBtheBsameB_________,BbutBhaveBdifferentB________
______:
a)BNumerator,BDenominatorsB
b)BDenominator,BNumerator
c)BMorbidBCuriosity,BMeanings
d)BProportion,BInterpretationsB-BBBa)BNumerator,BDenominators
ABcohortBstudyBenrollsBitsBparticipantsBbyB_______BandBthenBmeasuresBtheB_______
_.B
a)Boutcome,BhistoryBofBexposure
b)BdemographicBmetrics,BprevalenceBofBexposure
c)BexposureBstatus,BsubsequentBoutcome
d)BsurveyBalone,BoddsBratiosB-BBBc)BexposureBstatus,BsubsequentBoutcome
WhyBisBitBimportantBtoBunderstandBtheBtemporalBrelationshipBbetweenBanBexposure,B
andBanBoutcome?